Intranasal delivery of stem cells to the brain

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Expert Opinion on Drug Delivery

• Publication date

  2011-04-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/17425247.2011.566267PMID 21417782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats.

  2011cited by this paper
• Progress and prospects: stem cells and neurological diseases

  2011cited by this paper
• Gelatinized Copper–Capillary Alginate Gel Functions as an Injectable Tissue Scaffolding System for Stem Cell Transplants

  2011cited by this paper
• Intranasal clobazam delivery in the treatment of status epilepticus.

  2011cited by this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011influential reference
• Direct conversion of fibroblasts to functional neurons by defined factors

  2010cited by this paper
• Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

  2010cited by this paper
• A Long‐Term Follow‐Up Study of Intravenous Autologous Mesenchymal Stem Cell Transplantation in Patients With Ischemic Stroke

  2010cited by this paper
• Transnasal delivery of methotrexate to brain tumors in rats: a new strategy for brain tumor chemotherapy.

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS

  2010cited by this paper
• Nasal Administration of Stem Cells: A Promising Novel Route to Treat Neonatal Ischemic Brain Damage

  2010influential reference
• Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL*

  2010cited by this paper
• Direct Intrathecal Implantation of Mesenchymal Stromal Cells Leads to Enhanced Neuroprotection via an NFκB-Mediated Increase in Interleukin-6 Production

  2010cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Transplantation of Human Neural Precursor Cells in Matrigel Scaffolding Improves Outcome from Focal Cerebral Ischemia after Delayed Postischemic Treatment in Rats

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010cited by this paper
• 834 Useful Evaluation of Thromboelastography for Coagulation Disorders in Critically Ill Patients

  2010cited by this paper
• Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity.

  2010cited by this paper
• Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.

  2010cited by this paper
• Preparation and evaluation of fexofenadine microemulsion for intranasal delivery.

  2010cited by this paper
• Human neural stem cells genetically modified to overexpress brain‐derived neurotrophic factor promote functional recovery and neuroprotection in a mouse stroke model

  2010cited by this paper
• Biodistribution of Neural Stem Cells After Intravascular Therapy for Hypoxic–Ischemia

  2010cited by this paper
• Intraarterial autologous implantation of adult stem cells for patients with Parkinson disease.

  2010cited by this paper
• Nasal delivery of recombinant human growth hormone: in vivo evaluation with Pheroid technology and N-trimethyl chitosan chloride.

  2010cited by this paper
• Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

  2009cited by this paper
• Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease

  2009cited by this paper
• Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009cited by this paper
• Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.

  2009cited by this paper
• Novel Vasoconstrictor Formulation to Enhance Intranasal Targeting of Neuropeptide Therapeutics to the Central Nervous System

  2009cited by this paper
• Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration

  2009cited by this paper
• Combination therapy with intranasal NGF and electroacupuncture enhanced cell proliferation and survival in rats after stroke

  2009cited by this paper
• Intranasal delivery of cells to the brain.

  2009influential reference
• Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.

  2008cited by this paper
• Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

  2008cited by this paper
• Harmful Effects of Cadmium on Olfactory System in Mice

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats

  2008cited by this paper
• Subacute neural stem cell therapy for traumatic brain injury.

  2008cited by this paper
• Dual-Modality Monitoring of Targeted Intraarterial Delivery of Mesenchymal Stem Cells After Transient Ischemia

  2008cited by this paper
• Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

  2008cited by this paper
• New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

  2008cited by this paper
• Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis

  2008cited by this paper
• Intravenous Grafts Recapitulate the Neurorestoration Afforded by Intracerebrally Delivered Multipotent Adult Progenitor Cells in Neonatal Hypoxic-Ischemic Rats

  2008cited by this paper
• Molecular probes: insights into design and analysis from computational and physical chemistry.

  2008cited by this paper
• Nasal delivery of siRNA.

  2008cited by this paper
• Intranasal insulin improves cognition and modulates β-amyloid in early AD

  2008cited by this paper
• Intranasally delivered TGF-beta1 enters brain and regulates gene expressions of its receptors in rats.

  2007cited by this paper
• Blood Vessels Form a Scaffold for Neuroblast Migration in the Adult Olfactory Bulb

  2007cited by this paper
• Intranasal Insulin to Improve Memory Function in Humans

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.

  2006cited by this paper
• Enhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapy

  2006cited by this paper
• The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain.

  2006cited by this paper
• Videos in clinical medicine. Lumbar puncture.

  2006cited by this paper
• Transplantation of primed human fetal neural stem cells improves cognitive function in rats after traumatic brain injury.

  2006cited by this paper
• Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

  2006cited by this paper
• Mesenchymal Stem Cells Spontaneously Express Neural Proteins in Culture and Are Neurogenic after Transplantation

  2006cited by this paper
• Lineage‐negative bone marrow cells travel bidirectionally in the olfactory migratory stream but maintain hematopoietic phenotype

  2005cited by this paper
• The blood-brain barrier: Bottleneck in brain drug development

  2005cited by this paper
• Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.

  2005cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Brain Uptake of the Glucagon-Like Peptide-1 Antagonist Exendin(9-39) after Intranasal Administration

  2004cited by this paper
• Neonatal brain injury.

  2004cited by this paper
• Intranasal insulin improves memory in humans.

  2004cited by this paper
• Spread and Replication of and Immune Response to γ134.5-Negative Herpes Simplex Virus Type 1 Vectors in BALB/c Mice

  2004cited by this paper
• Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain

  2004cited by this paper
• Local vascular pathway for progesterone transfer to the brain after nasal administration in gilts.

  2003cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper
• Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.

  2002cited by this paper
• Filamentous phage as vector-mediated antibody delivery to the brain

  2002cited by this paper
• Sniffing neuropeptides: a transnasal approach to the human brain

  2002cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Experimental pneumococcal meningitis in mice: a model of intranasal infection.

  2001cited by this paper
• Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis.

  2001cited by this paper
• Anatomy, physiology and function of the nasal cavities in health and disease.

  1998cited by this paper
• Chain Migration of Neuronal Precursors

  1996cited by this paper
• Uptake of aluminium into central nervous system along nasal-olfactory pathways.

  1987cited by this paper
• Lumbar puncture.

  1980cited by this paper
• Tracing Burt's Descent to Scientific Fraud.

  1979cited by this paper
• Lumbar Puncture

  1958cited by this paper

• Multifunctional approaches of cubosome-integrated thermoresponsive gels for intranasal brain targeting: Innovations, therapeutic potential, and challenges

  2026cites this paper
• Del Río Hortega’s insights into oligodendrocytes: recent advances in subtype characterization and functional roles in axonal support and disease

  2025cites this paper
• Imaging technology in tracking the intravital fate of transplanted stem cells.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Oligodendrocyte and Myelin Pathophysiology in Multiple Sclerosis.

  2025cites this paper
• Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review.

  2024cites this paper
• Oligodendrocyte Progenitor Cell Transplantation Reduces White Matter Injury in a Fetal Goat Model

  2024influential citation
• Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.

  2024cites this paper
• Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis.

  2023cites this paper
• Combined Core Stability and Degradability of Nanomedicine via Amorphous PDLLA-Dextran Bottlebrush Copolymer for Alzheimer's Disease Combination Treatment.

  2023cites this paper
• Human umbilical cord-derived mesenchymal stem cells promote repair of neonatal brain injury caused by hypoxia/ischemia in rats

  2022cites this paper
• Bone marrow mesenchymal stem cells improve cognitive impairments induced by methamphetamine in rats and reduce relapse

  2022cites this paper
• Editing a gateway for cell therapy across the blood–brain barrier

  2022cites this paper
• Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration

  2022cites this paper
• CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology.

  2022cites this paper
• Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review

  2022cites this paper
• Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model

  2021cites this paper
• Diagnostic and Therapeutic Potential of Extracellular Vesicles

  2021cites this paper
• The Role of Extracellular Vesicles in the Developing Brain: Current Perspective and Promising Source of Biomarkers and Therapy for Perinatal Brain Injury

  2021cites this paper
• From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson's Disease.

  2021cites this paper
• Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine

  2021cites this paper
• Advances in intranasal application of stem cells in the treatment of central nervous system diseases

  2021cites this paper
• [Research progress of different types of stem cells in treatment of ischemic stroke].

  2021cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Nanoengineering of stem cells for neural regenerative medicine

  2020cites this paper
• Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.

  2020cites this paper
• Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis

  2020cites this paper
• Neurorestoration Approach by Biomaterials in Ischemic Stroke

  2020cites this paper
• Extracellular vesicles for tumor targeting delivery based on five features principle.

  2020cites this paper
• Nose ‐To ‐Brain Delivery of Mitochondria for Treatment of Parkinson’s Disease Model Rats With 6-Hydroxydopamine

  2020influential citation
• Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.

  2020cites this paper
• Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease

  2020cites this paper
• Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Golden Exosomes Selectively Target Brain Pathologies in Neurodegenerative and Neurodevelopmental Disorders.

  2019cites this paper
• Intracerebroventricular Administration of Neural Stem Cells after Cardiac Arrest

  2019cites this paper
• Human intracerebroventricular (ICV) injection of autologous, non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients

  2019cites this paper
• Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice

  2019cites this paper
• Application of olfactory ensheathing cells in clinical treatment of spinal cord injury: meta-analysis and prospect

  2019cites this paper
• The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke

  2019cites this paper
• Intranasal Delivery of Drugs for Ischemic Stroke Treatment: Targeting IL-17A

  2019cites this paper
• Feasibility of Mitochondrial Transplantation Via Nose‐To‐Brain Delivery for Treatment of Parkinson Diseases

  2018cites this paper
• The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives

  2018cites this paper
• Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy

  2018cites this paper
• Mesenchymal Stromal Cell Therapy of Stroke

  2018cites this paper
• Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents

  2017cites this paper
• Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.

  2017cites this paper
• Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy.

  2017cites this paper
• Drug delivery in overcoming the blood–brain barrier: role of nasal mucosal grafting

  2017cites this paper
• Route, Cell Dose, and Timing

  2017cites this paper
• Novel Protein Delivery Platforms to Modulate SDF-1α/CXCR4 Signaling in the Adult Cortex

  2016cites this paper
• Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage

  2016cites this paper
• Neurologic Stem Cell Treatment Study (NEST) using bone marrow derived stem cells for the treatment of neurological disorders and injuries: study protocol for a nonrandomized efficacy trial

  2016cites this paper
• Perillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain Metastases

  2016cites this paper
• Innate regulation of the adaptive immune system during autoimmunity

  2015cites this paper
• Neurodegenerative diseases – Understanding their molecular bases and progress in the development of potential treatments

  2015cites this paper
• Pathway and Effect of Intranasal Orexin

  2015cites this paper
• Opportunities and Challenges: Stem Cell‐Based Therapy for the Treatment of Ischemic Stroke

  2015cites this paper
• Intranasal delivery of hypoxia-preconditioned bone marrow-derived mesenchymal stem cells enhanced regenerative effects after intracerebral hemorrhagic stroke in mice.

  2015cites this paper
• Intranasal delivery: circumventing the iron curtain to treat neurological disorders

  2015influential citation
• Intranasal Delivery of Bone Marrow Mesenchymal Stem Cells Improved Neurovascular Regeneration and Rescued Neuropsychiatric Deficits after Neonatal Stroke in Rats

  2015cites this paper
• Bone Marrow–Derived Stem Cells and Strategies for Treatment of Nervous System Disorders

  2015cites this paper
• Biodistribution of in vitro-derived microglia applied intranasally and intravenously to mice: effects of aging.

  2015cites this paper
• Intranasal delivery of stem cells as therapy for central nervous system disease.

  2015cites this paper
• Roadmap of miR-122-related clinical application from bench to bedside

  2014cites this paper
• Stem Cell Therapies in Neurology

  2014cites this paper
• Cell based therapies for ischemic stroke: from basic science to bedside.

  2014cites this paper
• Intranasal delivery of central nervous system‐retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis

  2014cites this paper
• Intranasal delivery of FSD‐C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis

  2014cites this paper
• Intranasal nerve growth factor attenuates tau phosphorylation in brain after traumatic brain injury in rats.

  2014cites this paper
• Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice

  2014cites this paper
• MYELOID CELLS IN AUTOIMMUNE DISEASES

  2014cites this paper
• Feasibility of Delivering Mesenchymal Stem Cells via Catheter to the Proximal End of the Lesion Artery in Patients with Stroke in the Territory of the Middle Cerebral Artery

  2013cites this paper
• Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier: an excellent platform for brain targeting

  2013cites this paper
• Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?

  2013cites this paper
• MicroRNA: Not Far from Clinical Application in Ischemic Stroke

  2013cites this paper
• The Paradox Role of Regulatory T Cells in Ischemic Stroke

  2013cites this paper
• Intranasal administration: a potential solution for cross-BBB delivering neurotrophic factors.

  2012cites this paper
• Neurological disorders and the potential role for stem cells as a therapy.

  2012cites this paper
• CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

  2012cites this paper
• Cultivation of RPMI 2650 cells as an in‐vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions

  2012cites this paper
• Intranasal Treatment of Central Nervous System Dysfunction in Humans

  2012cites this paper
• A new approach with less damage: intranasal delivery of tetracycline-inducible replication-defective herpes simplex virus type-1 vector to brain.

  2012cites this paper
• Mesenchymal stem cells as therapeutic agents and potential targeted gene delivery vehicle for brain diseases.

  2012cites this paper
• Barriers of the Human Organism and Their Achilles’ Heels

  2012cites this paper
• Clinical trials of intranasal delivery for treating neurological disorders – a critical review

  2011cites this paper
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cites this paper
• Direct Intrathecal Implantation of Mesenchymal Stromal Cells Leads to Enhanced Neuroprotection via an NFκB-Mediated Increase in Interleukin-6 Production

  2010cites this paper
• Title: Nasal Drug Delivery System and it’s application

  year unknowncites this paper